Request A Consultation
Copyright © 2025 Kennedy Law Firm. All Rights Reserved, Reproduced with Permission
A class of drugs used to treat conditions such as arthritis may in crease the risk of cancer in younger people according to the FDA. The FDA will require drug manufacturers who make TNKblocking medications to revise labeling to reflect the increased risk of cancer. TNF blockers include Simponi, Humira and Enbrel, which already carry a black box warning. Susan Heavey, Reuters 08/05/2009